Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (8621)
All Articles published online
|
Publishing Process of This Article
|
Jun 26, 2022 (publication date) through Oct 22, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Clinical Cases
ISSN
2307-8960
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| Wu JY, Kang K, Yi J, Yang B. Pembrolizumab-induced Stevens-Johnson syndrome in advanced squamous cell carcinoma of the lung: A case report and review of literature. World J Clin Cases 2022; 10(18): 6110-6118 [PMID: 35949835 DOI: 10.12998/wjcc.v10.i18.6110] |
|
|
|
| ©2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA | |
| For: | Wu JY, Kang K, Yi J, Yang B. Pembrolizumab-induced Stevens-Johnson syndrome in advanced squamous cell carcinoma of the lung: A case report and review of literature. World J Clin Cases 2022; 10(18): 6110-6118 [PMID: 35949835 DOI: 10.12998/wjcc.v10.i18.6110] |
|---|---|
| URL: | https://www.wjgnet.com/2307-8960/full/v10/i18/6110.htm |
| Number | Citing Articles |
| 1 |
Yen T.H. Pham, Mai T. Vu, Anh Q. Nguyen, Phat N. Trinh, Mai H. Tran, Hieu C. Chu, Nguyet T.M. Nguyen, Chi H.V. Vu, Dinh V. Nguyen. Pembrolizumab-induced Stevens-Johnson syndrome/Toxic Epidermal Necrolysis in a Vietnamese patient with nonsmall-cell lung cancer. Asia Pacific Allergy 2024; 14(2): 84 doi: 10.5415/apallergy.0000000000000131
|
| 2 |
Yusuke Irie, Kazutoshi Isobe, Ryogo Ohashi, Kensuke Namba, Misa Iwayanagi, Hiromasa Sakurai, Daiki Sakai, Kenta Takashima, Yu Murakami, Kaichi Kaneko, Shinji Mitsuyama, Hiroki Wakabayashi, Yasuo Matsuzawa. A Case of Stevens–Johnson Syndrome Triggered by Methicillin‐Resistant Staphylococcus aureus Infection During Pembrolizumab Treatment for Lung Squamous Cell Carcinoma. Respirology Case Reports 2025; 13(7) doi: 10.1002/rcr2.70290
|
| 3 |
Christian L. Bailey-Burke, Kristin A. Tissera, Lauren Baughman, Samantha A. Polly, Meenal Kheterpal. Assessing Treatment Efficacy for Dermatologic Immune-Related Adverse Events: A Systematic Review. JID Innovations 2025; 5(6): 100410 doi: 10.1016/j.xjidi.2025.100410
|
| 4 |
|
| 5 |
|
| 6 |
Takashi K. Satoh, Matthias Munoz Neulinger, Pia‐Charlotte Stadler, Rui Aoki, Lars E. French. Immune checkpoint inhibitor‐induced epidermal necrolysis: A narrative review evaluating demographics, clinical features, and culprit medications. The Journal of Dermatology 2024; 51(1): 3 doi: 10.1111/1346-8138.17039
|
| 7 |
Vasiliki Chwiałkowska, Monika Słowińska, Anna Płatkowska, Joanna Kania, Karolina Parciak, Anna Czarnecka, Paweł Teterycz, Witold Owczarek. Superficial mucoceles as a sequel to Stevens‑Johnson syndrome during treatment of cutaneous squamous cell carcinoma with cemiplimab: A case report and review of literature. Experimental and Therapeutic Medicine 2024; 29(1) doi: 10.3892/etm.2024.12765
|
| 8 |
Jia Zhou, Chuan-Peng Wang, Jun Li, Han-Lin Zhang, Chun-Xia He. Stevens-Johnson syndrome and toxic epidermal necrolysis associated with immune checkpoint inhibitors: a systematic review. Frontiers in Immunology 2024; 15 doi: 10.3389/fimmu.2024.1414136
|
| 9 |
Maxine Gossell-Williams, Gabrielle McLaren, Rojay Clarke, Shenae Douglas, Devonne Gayle, Kerrian Guthrie. Rapid review of drug induced Stevens Johnson Syndrome case reports from 2003 to 2023: Trends among monoclonal antibodies and systemic immunosuppressant therapy. International Journal of Risk & Safety in Medicine 2025; doi: 10.1177/09246479251368022
|
| 10 |
Gunnar Mattson, Rodrigo Gutierrez, Anna Haemel, Kanade Shinkai, Ryan Arakaki, Lindy Fox, Allison Dobry. Stevens-Johnson syndrome-toxic epidermal necrolysis spectrum reactions to immune checkpoint inhibitor therapy and safety of rechallenge: A retrospective review. JAAD Case Reports 2025; 64: 189 doi: 10.1016/j.jdcr.2025.03.039
|